Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10040860 Therapeutic antibodies and their uses

Patent 10040860 was granted and assigned to Pfizer Limited on August, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
January 23, 2018
Date of Patent
August 7, 2018
Patent Application Number
15878344
Patent Citations Received
‌
US Patent 10294304 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 11912776 Chimeric antigen receptors targeting B-cell maturation antigen
0
‌
US Patent 11384153 Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
‌
US Patent 11312782 Chimeric antigen receptors targeting B-cell maturation antigen
0
Patent Inventor Names
Arvind Rajpal
0
Amy Shaw-Ru Chen
0
Wei Chen
0
Weihsien Ho
0
Yik Andy Yeung
0
Edward Derrick Pascua
0
Javier Fernando Chaparro Riggers
0
Leila Marie Boustany
0
Pavel Strop
0
Thomas John Van Blarcom
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10040860
Patent Primary Examiner
‌
Laura B Goddard

Find more entities like US Patent 10040860 Therapeutic antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo